88
Participants
Start Date
July 31, 2006
Primary Completion Date
December 1, 2011
Study Completion Date
December 1, 2011
Otelixizumab
Infusion
GSK Investigational Site, Worcester
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Baltimore
GSK Investigational Site, Jacksonville
GSK Investigational Site, Pinellas Park
GSK Investigational Site, Birmingham
GSK Investigational Site, Gulfport
GSK Investigational Site, Mentor
GSK Investigational Site, Kalamazoo
GSK Investigational Site, Minneapolis
GSK Investigational Site, Rapid City
GSK Investigational Site, Chicago
GSK Investigational Site, Omaha
GSK Investigational Site, Aurora
GSK Investigational Site, Walnut Creek
GSK Investigational Site, San Antonio
GSK Investigational Site, Toronto
Lead Sponsor
Collaborators (1)
Juvenile Diabetes Research Foundation
OTHER
GlaxoSmithKline
INDUSTRY